[Comparison of the effectiveness of lysine acetylsalicylate and metoclopramide combination with ergotamine plus caffeine in the treatment of migraine attacks].
Migraine is a common medical condition affecting more than 10% of population in Poland. Acute migraine attacks are often associated with gastrointestinal symptoms ranging from mild nausea to vomiting. The present study was specifically designed to compare the efficacy of the combination of lysine acetylsalicylate and metoclopramide (1620 mg LAS + 10 mg MTC--Migpriv) and ergotamine plus caffeine (2 mg ERG + 200 mg CAF--Coffecorn forte) in the treatment of migraine headache and nausea. 98 patients with migraine meeting HIS criteria were randomized. The primary endpoint was the number of patients having headache relief and no nausea or vomiting two hours after the drug intake. Significantly more Migpriv treated patients than Coffecorn ones were free of headache two hours after drug administration (58.7% vs. 35.7% respectively: p<0.002). Reported adverse events were rare and transient. Migpriv was significantly more effective than Coffecorn forte in relieving the migraine attack symptoms.
Z Kliniki Neurologii Wojskowego Instytutu Medycznego w Warszawie.
Adam
A
Stepień
Wojciech
W
Kozubski
D000328:Adult; D000368:Aged; D018712:Analgesics, Non-Narcotic / Q000008:administration & dosage*; D001241:Aspirin / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D002110:Caffeine / Q000008:administration & dosage*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage; D018492:Dopamine Antagonists / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D004878:Ergotamine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008239:Lysine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D008297:Male; D008787:Metoclopramide / Q000008:administration & dosage*; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy* / Q000503:physiopathology; D011044:Poland / Q000453:epidemiology; D013997:Time Factors; D016896:Treatment Outcome
D018712:Analgesics, Non-Narcotic; D000697:Central Nervous System Stimulants; D018492:Dopamine Antagonists; D002110:Caffeine; D008239:Lysine; D008787:Metoclopramide; D004878:Ergotamine; D001241:Aspirin; C010395:acetylsalicylic acid lysinate